✦ LIBER ✦

Antigen-presenting function of B-cell precursor malignant cells can be modulated by crosslinking of CD40

✍ Scribed by A. A. Cardoso; J. L. Schultze; D. Provan; G. J. Freeman; M. Seamon; J. G. Gribben; L. M. Nadler

Book ID: 112784536
Publisher: Springer-Verlag
Year: 1995
Tongue: English
Weight: 168 KB
Volume: 121
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf02571993

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FMC7 antigen expression on normal and ma

FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20

✍ Wolfgang Hübl; Jose Iturraspe; Raul C. Braylan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Most antibody panels proposed for flow cytometric immunophenotyping of non-Hodgkin's lymphomas and chronic lymphoid leukemias include anti-CD20 and FMC7 antibodies. As in our experience, reactivity of B-cells with these antibodies seemed to be correlated, we evaluated whether the simultaneous use of

Differentiation of human in vivo antigen

Differentiation of human in vivo antigen-induced lymphoblastoid B cell precursors can be prevented by natural killer cells

✍ Ana Garcia-Alonso; Jose A. Brieva 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 686 KB

B cells can prime naive CD4+ T cells in

B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner

✍ Daniel Rodríguez-Pinto; José Moreno 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

Expansion or Elimination of B Cells In V

Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen Receptor

✍ Jeffrey C Rathmell; Sarah E Townsend; Jiachao C Xu; Richard A Flavell; Christoph 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Enhancement of antigen-presenting abilit

Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody

✍ Weilin Chen; Yizhi Yu; Chuansen Shao; Minhui Zhang; Wenya Wang; Lihuang Zhang; X 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Anti-CD3-based bispecific antibody desig

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies